By G HossainPosted on July 30, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026. Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill Post navigation Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 EarningsHookipa Winds Down, Merck Trims Billions in ‘Reallocation’